Aristo Pharmaceuticals Walk-In Interview for various Positions On 28th Aug’ 2022

Join Telegram

Aristo Pharmaceuticals driving Walk-In-Interview for various departments QA, QC, Production /Packing, Maintenance, Store/ BSR On 28th Aug’ 2022

Aristo Pharmaceuticals Walk-In-Interview for Various Positions

About Company:

ARISTO Pharmaceuticals Pvt. Ltd., an Indian pharmaceutical company founded in 1971, has a product portfolio of more than 300 items and annual revenue of $427 million. It is currently active in more than 30 countries. In India, Aristo has four cutting-edge manufacturing facilities located in Baddi, Daman, Mandideep, and Sikkim.

One of the biggest manufacturers of injectable Cephalosporins in India is ARISTO.

Position Description

Walk-In Interviews for Departments at Aristo Pharmaceuticals Pvt. Ltd. on August 28, 2022, for QA, QC, Production/Packing, Maintenance, Store, and BSR

Departmental Position: QA, QC, Production/Packing, Maintenance, Store/BSR,

Required Qualification: B.Pharma, M.Pharma, M.Sc, B.Sc, B.Tech, Diploma, or Graduate degree is required.

Years of experience: 2 to 7

Positions: Supervisors, Chemists, and Officers

Workplace: Sikkim

Walk-in-Interview Date and time

Date: August 28, 2022

9:30 a.m. to 3:00 p.m.

Interview location: Baghey Khola, Majitar, East Sikkim, Aristo Pharmaceuticals Pvt. ltd

Related Post: Sunrise International Labs Ltd Walk-In Interviews

Contact Details:

Contact us for any inquiries at +91 7047075555 or 7047076666, or send your most recent resume to [email protected]

Leave a Comment

Your email address will not be published.

Join Telegram

Get Direct Jobs Notification


This will close in 15 seconds

Granules India Pvt. Limited-Walk-In Interviews 10 Largest Pharmaceutical Companies in USA List of the Best Paying Jobs in the Healthcare Industry USA. Lupin Biotech Limited -Walk-In Drive on 21, Aug 2022 Zydus receives Form 483 from the USFDA for 4 observations. क्या पैन किलर आपकी kidney को मार रही है? SUN PHARMA – Walk-In Interviews for Pharma candidates Purdue Pharma, Sacklers reach $6 billion deal USA